Top Articles

This plenary symposium captured the overarching theme of the Congress. Professor Vezzani from Milan began by discussing neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy. There is evidence for oxidative stress and neuroinflammatory responses in various forms of epilepsy, from animal models and surgical resection specimens, with microglial activation, extravasation of albumin, and upregulation of proinflammatory cytokines, such as interleukin 1-beta.

The Brain Prize Lecture: The prodromal cellular phase of Alzheimer’s disease (AD): toward a novel understanding of the disorder Charles Edouard Brown-Séquard Lecture: Do we need to reinvent translational cerebrovascular research? The Moritz Romberg Lecture: Translational neuroscience to improve outcomes for MND: are we winning?

The Charles Edouard Brown-Séquard Lecture at EAN 2019 was delivered by Prof. Ulrich Dirnagl, who had a chat with EAN eCommunciations Board Co-Chair, PD DR. Tim von Oertzen about his work.

Prof. Claudio Bassetti, President Elect of EAN, met with Prof. Bart de Strooper winner of the Lundbeck Foundation's Brain Prize 2018

Following her lecture at EAN 2019 in Oslo, Dr. Tom Jenkins, EAN eCommunciations board member and incoming editor-in-chief of EANpages, spoke to Prof. Dame Pamela Shaw following her Moritz Romberg Lecture at EAN 2019.

Prof. Hugh Willison from Glasgow discussed the pathogenesis of immune-mediated neuropathies, focusing especially on GBS. New inputs are the uptake of GM1 antibodies into spinal cord/motor roots, glycoarray techniques to detect antibodies against gangliosides -complexes, and neuropathies related to immune check-point inhibitors.

The joint special session of the corresponding members to EAN and AFAN was dedicated to “Intractable epilepsies”. The session was chaired by Prof. Jean-Michel Vallat (Limoges, France) and Prof. Erich Schmutzhard (Innsbruck, Austria).

Professor Schneider spoke about metabolic movement disorders using a treatment-based approach, with Wilson’s disease, PKAN, GLUT1-spectrum disorders, Gaucher and GBA-associated Parkinson’s disease as examples.

Biomarkers in degenerative dementia: news and views from the European Dementia with Lewy Body (DLB) Consortium This symposium was co-chaired by Flavio Nobilli, from Genova, and Dag Aarsland, from London.

In this session, excellent speakers reviewed the past, present and future of headache treatment, starting from headache pathophysiology and explaining where do the different therapies act specifically.

Under the high patronage of C. Tassorelli (Pavia, Italy) and S. Evers (Münster, Germany), acting as speakers and chairpersons, this symposium focused on a rather uncomfortable topic – unmet needs in the management of migraine. The session began with C. Tassorelli’s presentation on Refractory Migraine Attacks.

Congress delegates flocked to the main auditorium last night to witness the official opening of the fifth congress of the European Academy of Neurology.

Norwegian team takes on rest of world in exciting battle of the brains! The BrainChallenge took place today at EAN 2019, for the second time following the success of its introduction in Lisbon at last year’s congress.  It proved to be even more popular the second-time round, and every bit as much fun.  The tension and excitement could be felt in the room as the local team from Norway had to face a formidable international team made up of delegates from several countries.

4 days to Oslo

12 days to Oslo